Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
4.60
-0.39 (-7.82%)
At close: Jun 17, 2025, 2:17 PM
-7.82% (1D)
| Bid | 4.56 |
| Market Cap | 216.71M |
| Revenue (ttm) | 42.2M |
| Net Income (ttm) | -33.47M |
| EPS (ttm) | -1.65 |
| PE Ratio (ttm) | -2.79 |
| Forward PE | -31.44 |
| Analyst | Buy |
| Ask | 4.69 |
| Volume | 2,762 |
| Avg. Volume (20D) | 11,881.7 |
| Open | 4.99 |
| Previous Close | 4.99 |
| Day's Range | 4.53 - 4.99 |
| 52-Week Range | 2.76 - 6.00 |
| Beta | 1.56 |
About NBTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+18.51%
Nanbotix shares are trading higher after the compa...
Unlock content with
Pro Subscription
4 months ago
+7.26%
Nanobiotix shares are trading higher after the company announced it began its Phase 2 trial for an innovative cancer treatment in stage 3 lung cancer.
